Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2018 Jan 3;31(1):88-89.
doi: 10.1080/08998280.2017.1400300. eCollection 2018 Jan.

Chronic neutrophilic leukemia

Affiliations
Case Reports

Chronic neutrophilic leukemia

Arthur Bredeweg et al. Proc (Bayl Univ Med Cent). .

Abstract

Chronic neutrophilic leukemia is a rare myeloproliferative disorder characterized by a sustained peripheral blood neutrophilia, absence of the BCR/ABL oncoprotein, bone marrow hypercellularity with less than 5% myeloblasts and normal neutrophil maturation, and no dysplasia. This leukemia has been associated with mutations in the colony-stimulating factor 3 receptor (CSF3R) that may activate this receptor, leading to the proliferation of neutrophils that are the hallmark of chronic neutrophilic leukemia. We present a case of chronic neutrophilic leukemia and discuss the criteria for diagnosis and the significance of mutations found in this leukemia.

Keywords: CSF3R; Chronic neutrophilic leukemia; RUNX1; SETBP1; SRSF2; myeloproliferative disorder.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
(a) Peripheral blood (Wrights, ×500). (b) Bone marrow aspirate (Wrights, ×500). (c) Bone marrow core biopsy (hemotoxylin and eosin, ×400).

References

    1. Arber DA, Orazi A, Hasserjian R, et al.. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391–2405. doi:10.1182/blood-2016-03-643544. - DOI - PubMed
    1. Pardanani A, Lasho TL, Laborde RR, et al.. CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia. Leukemia. 2013;27(9):1870–1873. doi:10.1038/leu.2013.122. - DOI - PMC - PubMed
    1. Maxson JE, Gotlib J, Pollyea DA, et al.. Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML. N Engl J Med. 2013;368(19):1781–1790. doi:10.1056/NEJMoa1214514. - DOI - PMC - PubMed
    1. Gotlib J, Maxson JE, George TI, Tyner JW. The new genetics of chronic neutrophilic leukemia and atypical CML: implications for diagnosis and treatment. Blood. 2013;122(10):1707–1711. doi:10.1182/blood-2013-05-500959. - DOI - PMC - PubMed
    1. Cui Y, Li B, Gale RP, et al.. CSF3R, SETBP1 and CALR mutations in chronic neutrophilic leukemia. J Hematol Oncol. 2014;7(1):77–81. doi:10.1186/s13045-014-0077-1. - DOI - PMC - PubMed

Publication types

LinkOut - more resources